Agios Pharma(DE:8AP)
€28.40+1.20 (+4.41%)
DE:8AP
Agios Pharma earnings date
€28.40
At close:+1.20 (+4.41%)
Agios Pharma (8AP) Q2 2020 Earnings Report
0 Followers
DE:8AP Q2 2020 EPS Results
- Actual EPS
- -EUR 1.17
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 1.67
DE:8AP Q2 2020 Revenue Results
- Actual Revenue
- EUR 33.44M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- +42.43%
Earnings Announcement Details
- Quarter
- Q2 2020
- Date
- 07/30/2020
- Time
- Before Open
- Conference Call
- Thursday, July 30, 2020
DE:8AP Upcoming Earnings
Agios Pharma's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q2 2020 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2020 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2020 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8AP Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.98- | -1.67 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -1.11-0.98 | -1.59 | 38.76% (+0.62) | |
| Jul 30, 2026 | 2026 (Q2) | -1.48-1.51 | -1.73 | 12.44% (+0.21) | |
| Apr 29, 2026 | 2026 (Q1) | -1.61-1.51 | -1.39 | -9.03% (-0.13) | |
| Feb 12, 2026 | 2025 (Q4) | -1.75-1.67 | -1.29 | -29.17% (-0.38) | |
| Oct 30, 2025 | 2025 (Q3) | -1.70-1.59 | 14.52 | -110.97% (-16.12) | |
| Jul 31, 2025 | 2025 (Q2) | -1.62-1.73 | -1.51 | -14.20% (-0.21) | |
| May 01, 2025 | 2025 (Q1) | -1.59-1.39 | -1.3 | -6.90% (-0.09) | |
| Feb 13, 2025 | 2024 (Q4) | -1.51-1.29 | -1.53 | 15.79% (+0.24) | |
| Oct 31, 2024 | 2024 (Q3) | 13.6214.52 | -1.47 | 1089.02% (+15.99) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
